Your session is about to expire
← Back to Search
Procedure
Experimental approach for Lymphocele
N/A
Waitlist Available
Research Sponsored by Hartford Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
scheduled to undergo robotic assisted radical prostatectomy with pelvic lymph node dissection for prostate cancer at Hartford Hospital.
diagnosed with biopsy-proven prostate cancer, with intermediate or high risk features per D'Amico risk stratification
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Study Summary
Peritoneal Iliac Flap and Lymphocele Formation After Robotic Radical Prostatectomy
Eligible Conditions
- Lymphocele
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Lymphocele formation
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental approachExperimental Treatment1 Intervention
lymph node dissection using the peritoneal iliac flap approach to seal lymphatic vessels
Group II: Standard surgical approachActive Control1 Intervention
standard lymphadenectomy using clips and bipolar cautery to seal lymphatic vessels
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
lymph node dissection using the peritoneal iliac flap approach to seal lymphatic vessels
2018
N/A
~230
Find a Location
Who is running the clinical trial?
Hartford HospitalLead Sponsor
133 Previous Clinical Trials
18,705 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger